CAS 141102-74-1
:2-(Dimethylamino)ethyl N,N-dimethylphosphoramidofluoridate
Description:
2-(Dimethylamino)ethyl N,N-dimethylphosphoramidofluoridate, with the CAS number 141102-74-1, is a chemical compound that belongs to the class of organophosphorus compounds. It is characterized by the presence of a phosphoramidate functional group, which includes a phosphorus atom bonded to both nitrogen and fluorine atoms. This compound typically exhibits high reactivity due to the presence of the fluorine atom, which can enhance its electrophilic properties. The dimethylamino groups contribute to its basicity and potential for nucleophilic interactions. It is often studied for its potential applications in various fields, including agriculture and pharmaceuticals, particularly as a pesticide or herbicide. However, due to its organophosphorus nature, it may also pose risks related to toxicity and environmental impact. Proper handling and safety measures are essential when working with this compound, as it may exhibit harmful effects on human health and ecosystems.
Formula:C6H16FN2O2P
InChI:InChI=1S/C6H16FN2O2P/c1-8(2)5-6-11-12(7,10)9(3)4/h5-6H2,1-4H3
InChI key:InChIKey=SQOVUABAJBECMK-UHFFFAOYSA-N
SMILES:O(P(N(C)C)(F)=O)CCN(C)C
Synonyms:- 2-(Dimethylamino)Ethyl Dimethylphosphoramidofluoridate
- 2-(Dimethylamino)ethyl N,N-dimethylphosphoramidofluoridate
- Dimethylphosphoramidofluoridic acid 2-(dimethylamino)ethyl ester
- GP (chemical warfare agent)
- GV (chemical warfare agent)
- GV Substance
- GV-Phosphoramidofluoridate
- Phosphoramidofluoridic acid, N,N-dimethyl-, 2-(dimethylamino)ethyl ester
- Phosphoramidofluoridic acid, dimethyl-, 2-(dimethylamino)ethyl ester
- 2-Dimethylaminoethyl-(dimethylamido)fluorophosphate
- GV
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
2-(Dimethylamino-Fluorophosphoryl)Oxy-N,N-Dimethylethanamine
CAS:Controlled Product<p>2-(Dimethylamino-Fluorophosphoryl)Oxy-N,N-Dimethylethanamine (DMAPED) is a histone deacetylase inhibitor that has been shown to be active against infectious diseases in women. It has been shown to reduce the expression of HDACs and increase the expression of H3 acetylation. DMAPED has also been shown to have anti-inflammatory effects on skin cells through its ability to regulate the production of growth factors, such as epidermal growth factor. This drug is an effective treatment for skin disorders caused by an overactive immune system, such as psoriasis and atopic dermatitis. DMAPED blocks transcription by inhibiting the polymerase chain reaction, which results in decreased production of inflammatory cytokines. DMAPED is also used as a model system for studying meiosis in oocytes and its physiological function during this process.</p>Formula:C6H16FN2O2PPurity:Min. 95%Molecular weight:198.18 g/mol
